Renal Cancer - Results from #9040

The emerging role of targeted therapy in renal cell carcinoma (RCC): Is it time for a neoadjuvant or an adjuvant approach? - Abstract April 6, 2011

EAU 2011 - Head-to-head comparison of the most relevant integrated prognostic systems predicting cancer-specific survival in clear cell renal cell carcinoma - Session Highlights April 6, 2011

EAU 2011 - External validation of Karakiewicz preoperative and postoperative prognostic nomograms for renal cell carcinoma. A multicentre European study - Session Highlights April 6, 2011

A phase 1 study of everolimus and sorafenib for metastatic clear cell renal cell carcinoma - Abstract April 5, 2011

Antitumor effect of sunitinib against skeletal metastatic renal cell carcinoma through inhibition of osteoclast function - Abstract April 5, 2011

Rate of renal cell carcinoma subtypes in different races - Abstract April 4, 2011

Von Hippel-Lindau disease: A clinical and scientific review - Abstract April 4, 2011

Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population - Abstract April 1, 2011

Cryoablation of renal fossa recurrence after radical nephrectomy - Abstract April 1, 2011

Clinical practice guidelines for the treatment of metastatic renal cell carcinoma: Today and tomorrow - Abstract March 31, 2011

Diffusion-weighted magnetic resonance imaging in evaluation of primary solid and cystic renal masses using the Bosniak classification - Abstract March 31, 2011

UT Southwestern research advances fight against kidney cancer March 31, 2011

Beyond traditional outcomes: Improving quality of life in patients with renal cell carcinoma - Abstract March 30, 2011

Treatment-associated adverse event management in the advanced renal cell carcinoma patient treated with targeted therapies - Abstract March 30, 2011

Tumor biology and prognostic factors in renal cell carcinoma - Abstract March 29, 2011

Targeted therapies for the treatment of metastatic renal cell carcinoma: Clinical evidence - Abstract March 29, 2011

Clinical results and pharmacokinetics of sorafenib in chronic hemodialysis patients with metastatic renal cell carcinoma in a single center - Abstract March 28, 2011

Monitoring peri-operative immune suppression in renal cancer patients - Abstract March 28, 2011

Retrospective analyses of patient characteristics having predictive impact on survival under everolimus - Abstract March 25, 2011

The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus - Abstract March 25, 2011

Page 453 of 456